Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

The neuropathological confirmation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles (NFT) remains the gold standard for a definitive diagnosis of Alzheimer’s disease (AD). Nowadays, the in vivo diagnosis of AD is greatly aided by both cerebrospinal fluid (CSF) and positron emission tomograp...

Descripción completa

Detalles Bibliográficos
Autores principales: Lantero Rodriguez, Juan, Karikari, Thomas K., Suárez-Calvet, Marc, Troakes, Claire, King, Andrew, Emersic, Andreja, Aarsland, Dag, Hye, Abdul, Zetterberg, Henrik, Blennow, Kaj, Ashton, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423866/
https://www.ncbi.nlm.nih.gov/pubmed/32720099
http://dx.doi.org/10.1007/s00401-020-02195-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423866/
https://www.ncbi.nlm.nih.gov/pubmed/32720099
http://dx.doi.org/10.1007/s00401-020-02195-x

Ejemplares similares